Literature DB >> 8560754

Applications of DNA amplification techniques in veterinary diagnostics.

M Pfeffer1, M Wiedmann, C A Batt.   

Abstract

An overview of the principles of the polymerase chain reaction, ligase chain reaction, self-sustained sequence replication and Q beta replicase is given. The application of these methods for the diagnosis of veterinary infectious and hereditary diseases as well as for other diagnostic purposes is discussed and comprehensive tables of reported assays are provided. Specific areas where these DNA-based amplification methods provide substantial advantages over traditional approaches are also highlighted. With regard to PCR-based assays for the detection of viral pathogens, this article is an update of a previous review by Belák and Ballagi-Pordány (1993).

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 8560754      PMCID： PMC7089009          DOI： 10.1007/bf01839319

Source DB:  PubMed          Journal:  Vet Res Commun        ISSN： 0165-7380            Impact factor:   2.459


  261 in total

1.  Diagnosis of equid herpesviruses -1 and -4 by polymerase chain reaction.

Authors:  P C Sharma; A A Cullinane; D E Onions; L Nicolson
Journal:  Equine Vet J       Date:  1992-01       Impact factor: 2.888

2.  Detection of reticuloendotheliosis virus infection using the polymerase chain reaction.

Authors:  M M Aly; E J Smith; A M Fadly
Journal:  Avian Pathol       Date:  1993-09       Impact factor: 3.378

3.  Determination of the detection limit of the polymerase chain reaction for chicken infectious anemia virus.

Authors:  C Soiné; S K Watson; E Rybicki; B Lucio; R M Nordgren; C R Parrish; K A Schat
Journal:  Avian Dis       Date:  1993 Apr-Jun       Impact factor: 1.577

4.  Nucleotide sequence of the splice junction of feline leukemia virus envelope mRNA.

Authors:  M D Papenhausen; J Overbaugh
Journal:  Virology       Date:  1993-08       Impact factor: 3.616

5.  DNA restriction fragment length polymorphism among British isolates of Aujeszky's disease virus: use of the polymerase chain reaction to discriminate among strains.

Authors:  M Banks
Journal:  Br Vet J       Date:  1993 Mar-Apr

6.  Sexing and detection of gene construct in microinjected bovine blastocysts using the polymerase chain reaction.

Authors:  S Horvat; J F Medrano; E Behboodi; G B Anderson; J D Murray
Journal:  Transgenic Res       Date:  1993-05       Impact factor: 2.788

7.  Differentiation of Toxoplasma gondii from closely related coccidia by riboprint analysis and a surface antigen gene polymerase chain reaction.

Authors:  P J Brindley; R T Gazzinelli; E Y Denkers; S W Davis; J P Dubey; R Belfort; M C Martins; C Silveira; L Jamra; A P Waters
Journal:  Am J Trop Med Hyg       Date:  1993-03       Impact factor: 2.345

8.  Unique oligonucleotide primers in PCR for identification of Cryptococcus neoformans.

Authors:  T G Mitchell; E Z Freedman; T J White; J W Taylor
Journal:  J Clin Microbiol       Date:  1994-01       Impact factor: 5.948

9.  Diagnosis of equine influenza by the polymerase chain reaction.

Authors:  J C Donofrio; J D Coonrod; T M Chambers
Journal:  J Vet Diagn Invest       Date:  1994-01       Impact factor: 1.279

10.  Rapid detection of African horsesickness virus by the reverse transcriptase polymerase chain reaction (RT-PCR) using the amplimer for segment 3 (VP3 gene).

Authors:  K Sakamoto; R Punyahotra; N Mizukoshi; S Ueda; H Imagawa; T Sugiura; M Kamada; A Fukusho
Journal:  Arch Virol       Date:  1994       Impact factor: 2.574
View more
  2 in total

1.  Development of reverse transcription-PCR assays specific for detection of equine encephalitis viruses.

Authors:  B Linssen; R M Kinney; P Aguilar; K L Russell; D M Watts; O R Kaaden; M Pfeffer
Journal:  J Clin Microbiol       Date:  2000-04       Impact factor: 5.948

2.  Detection of challenge virus in fetal tissues by nested PCR as a test of the potency of a porcine parvovirus vaccine.

Authors:  S Belák; E Rivera; A Ballagi-Pordány; W Hanzhong; F Widén; T Soós
Journal:  Vet Res Commun       Date:  1998-02       Impact factor: 2.459
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.